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doi:10.1016/j.ejvs.2010.06.008Abstract Objectives: This study was designed to assess the accuracy and reliability of a new,
portable, fully automated photoplethysmography (PPG) device for toe blood pressure (TBP)
measurement.
Design: Within-subject comparison with conventional laser Doppler (LD) measurement.
Materials and methods: Four TBP measurements were performed on both lower limbs, alter-
natively with LD and PPG in 200 patients recruited at the Nıˆmes University Hospital. Reproduc-
ibility was assessed by the intraclass correlation coefficient (ICC). The concordance between
the two methods was evaluated by Lin’s concordance correlation coefficient (CCC), in the
whole population as well as in comorbidity subgroups. A potential bias was investigated with
the Bland and Altman method.
Results: The ICCwas 0.887 (95% confidence interval (CI) 0.852e0.913) and 0.893 (0.860e0.918) on
the right side (nZ 193), 0.905 (0.875e0.928) and 0.898 (0.866e0.922) on the left side (nZ 188) for
PPG and LD measurements, respectively. The CCC was 0.913 (0.885e0.934) on the right side and
0.915 (0.888e0.937) on the left side, and remained >0.8 regardless of co-morbidities.
Conclusions: This new, fully automatic, photoplethysmographic device yielded reliable TBP
measurements and showed good agreement with the reference LD system over a wide range of
values.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.d’Exploration et Me´decine Vasculaire, CHU de Nıˆmes, Place du Pr R Debre´, 30029 Nıˆmes Cedex 9,
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516 A. Pe´rez-Martin et al.Peripheral arterial disease (PAD) is a common consequence measurement sites. All participants gave written informedof systemic atherosclerosis, but may remain clinically
silent, especially in sedentary subjects or in diabetic
patients with peripheral neuropathy. Asymptomatic forms
are thus believed to be more common than symptomatic
forms, but both are associated with an increased risk of
cardiovascular mortality and morbidity, in addition to local
trophic complications.1e3 Therefore, screening for PAD
appears to be of importance and requires an accurate,
quick and cost-effective diagnostic approach.
The ankle brachial pressure index (ABI) is a sensitive and
specific method4 not only for diagnosing but also for
assessing the severity of PAD,5 and is largely
recommended.6
However, ABI measurement requires specific tools (blood
pressure cuffs and handheld 5e10-MHz continuous-wave
Doppler probe), is operator dependent, time consuming7
and remains underused, especially in outpatients. More-
over, its reliability is limited or compromised when medial
calcinosis reduces peripheral artery compressibility, espe-
cially in patients with diabetes, chronic renal failure or
advanced age, in whom the risk of PAD is greater.8,9
Measuring systolic blood pressure at the toe (TBP) and
calculating the toe-brachial index (TBI) has been proposed
to overcome this limitation because small distal arteries are
less prone to medial calcinosis.10e13 Although some authors
consider the TBI useful only in patients with elevated ABI
(i.e., >1.3),10 others emphasise the risk of falsely normal
ABI in patients with moderate incompressibility of ankle
arteries.11
However, TBP measurement also requires specific
equipment, including small pneumatic cuffs and plethys-
mography or laser Doppler (LD) devices, and its validity
depends on its use by skilled and meticulous operators.
Several specialised systems have been developed, the more
recently validated using laser Doppler.14 So far, the use of
such devices on a large-scale has been hampered by their
complexity and/or cost, so that TBP is often regarded as
unsuitable for the outpatient clinic.
This is why we developed a new miniaturised and fully
automated TBP measurement device using photo-
plethysmography (PPG) flow detection, with automatic
pulp blood draining as well as occlusion cuff inflation and
deflation. We assessed the usability, accuracy and reli-
ability of this device in a large sample of patients with and
without cardiovascular risk factors or expected PAD, using
a within-subject comparative design with conventional, LD
laboratory equipment.
Materials and Methods
Subjects
A 200-subject study population sample was recruited at the
Nıˆmes University Hospital over a 4-month period from in-
and outpatients aged 18 years or over: a total of 50
consecutive diabetic patients admitted to the Department
of Diabetes and Metabolic Medicine, 50 patients from the
Department of Internal Medicine and 100 patients referred
to the Department of Vascular Medicine. Exclusion criteria
were marked limb tremor or skin ulceration on toeconsent. The study protocol was approved by the local
Ethics Committee and conducted in accordance with the
Declaration of Helsinki.
Experimental procedure
Room temperature was maintained at 24e25 C. Individuals
were rested in a supine position and acclimatised for at
least 10 min. Information on patient demographics and co-
morbidities was collected with a questionnaire and medical
record analysis, especially as regards diabetes, hyperten-
sion, PAD, distal ulcer and smoking habits.
Brachial blood pressure
Systolic and diastolic blood pressures were measured at
rest in supine position, using an automated system (Dina-
map DPC-320N, GE Medical Systems, Milwaukee, WI, USA).
Toe pressure measurement
All measurements were performed on the first toe of both
lower limbs, if available, or on the second toe, if not. Prior
to blood pressure measurement, one sequence of infla-
tionedeflation of the pneumatic cuffs was completed but
not recorded to avoid or limit post-ischaemic effects. Toe
systolic pressure assessments were repeated for a total of
four measurements, twice with the new PPG device e
SysToe (Atys Medical, Soucieu-en-Jarrest, France,Patent #
08 58291, 5 December 2009), and twice with the reference
LD system (PF 5010 Doppler Laser monitor, Perimed,
Stockholm, Sweden), the techniques being used alterna-
tively in a randomised order, one technique followed by the
other one (e.g., LD, PPG, LD, PPG or PPG, LD, PPG, LD).
TBP measurement with LD was conducted according to
the manufacturer’s instructions. After wrapping the
appropriately sized pneumatic cuff around the first phalanx
of the toe, the laser probe was placed distal to the cuff on
the toe pulp. Pulp blood draining was performed manually
by gentle compression immediately before inflating the
occlusion cuff to 250 mmHg. The cuff was then automati-
cally and linearly deflated. Systolic blood pressure was read
automatically by software when the LD probe detected the
return of blood perfusion (Fig. 1).
For blood pressure measurement with the PPG device, an
appropriately sized pneumatic cuff (occlusion cuff) was
wrapped around the first phalanx of the toe. The PPG sensor
was placed on the toe pulp and maintained with a second
pneumatic cuff (blood draining cuff) delicately wrapped so
that it fitted the toe without applying any pressure when
deflated. Turning on the device launched an automatic
sequence starting with inflation of the blood draining cuff,
then inflation of the occlusion cuff followed by deflation of
the blood draining cuff, after which the occlusion cuff was
slowly and linearly deflated. The infrared PPG system,
working in reflection mode at 880 nm wavelength, with
a fixed power of 75mW, provided penetration depth of about
3 mm in the skin. During deflation, the return of blood
perfusion was detected when the direct current (DC) curve
showed a continuous upslope indicating a steady increase in
toe blood volume (Fig. 1). The pressure measured within the
occlusion cuff at the beginning of this upslope was assumed
to correspond to local systolic blood pressure.
Figure 1 Print of a typical automatic toe blood pressure
measurement with laser Doppler (LD) and photo-
plethysmography (PPG) in a patient with peripheral arterial
disease. Time is shown on the horizontal axis. On the LD curve
(upper part of the graph), the figures along the horizontal axis
correspond to the instantaneous pressure in the occlusion cuff,
whereas the curve shows the LD signal. On PPG curve (lower
part of the graph), the blue curve shows the pressure in the
occlusion cuff, read in mm Hg on the left scale, whereas the
red curve shows the PPG signal in % of its maximum amplitude
change during the measurement sequence.
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For each measurement device and each lower limb,
reproducibility was assessed by the intraclass correlation
coefficient (ICC) between the two repeated pressure
measurements. This reliability index was computed as
described by Carrasco et al.,15 the individual effect in the
model being considered as a random effect. The measure-
ment model was thus yij Z m þ ui þ 3ij in which 3ijeN(0,s2)
and uij e N(0,t
2) are independent and yij denotes the
measurement for individual i at occasion j. This model
decomposes the total variance between error variance (s2)
and inter-individual variance (t2). Then, ICCZ t2/(t2 þ s2)
is the proportion of the total variance that is due to
subjects. The reproducibility of a method of measurement
is judged acceptable when the ICC is higher than 0.8.
The concordance between the two methods of
measurement was assessed by the concordance correlation
coefficient (CCC) of Lin.16 The concordance computation
was based on the average of the two measurements done
by each device on each lower limb if the devices were
separately judged reproducible, and on the first and second
measurement separately, otherwise.
The Bland and Altman method was used to search for
a potential bias between the devices.
Reproducibility of measurements and concordance of
devices were assessed on the whole sample, by department,
and on subsamples defined by co-morbidities. Reproduc-
ibility and concordance were also assessed for TBI.
Each of the two lower limbs was treated separately to
avoid an additional source of variability.
All coefficient estimates are given with their 95% confi-
dence interval (CI). Data management and statisticalanalysis were performed under R software version 2.9.2 (R
Development Core Team (2009), R Foundation for Statis-
tical Computing, Vienna, Austria.)
Results
LD measurement could not be obtained in two subjects
because of tremor artefacts. PPG measurements were
possible in all 200 subjects. TBP measurement could not be
performed by either method in five right lower limbs and in
10 left lower limbs where toes or legs had been amputated.
Therefore, 193 right lower limbs and 188 left lower limbs, in
114 males and 84 females, were available for comparison.
There were 109 (55%) diabetic patients, 51 (25.6%) patients
with identified PAD, 82 (41.4%) patients with arterial
hypertension, 23 (11.6%) patients with distal ulcers and 58
(29.3%) smokers (Table 1).
Although the average time for measurements was similar
between the two systems, the software procedure was
longer with the LD device (software initialisation and
patients’ identification) than with PPG system. Typically;
a series of measurements lasts about 5 min with the PPG
versus about 10 min with the LD system. For the present
study, the entire procedure (i.e., two measurements with
each device) took about 15 min to complete.
The ICC was 0.887 (95% CI 0.852e0.913) and 0.893
(0.860e0.918) on the right side, 0.905 (0.875e0.928) and
0.898 (0.866e0.922) on the left side, respectively, for PPG
and LD measurements.
The CCC of systolic pressure and TBI for all subjects and
for each subgroup are reported in Table 2. Concordance
was fair (CCC >0.8), or good (>0.9) in most subgroups. The
analysis was not done for patients with ulcers, because the
number of subjects in this subgroup was too small. The
concordance was not altered by systolic pressure level and
remained above 0.8, regardless of brachial pressure values.
Fig. 2 shows LD versus PPG measurements for each lower
limb. The 45 line through the origin represents the perfect
situation of concordance. The best linear regression model
explaining LD measurement values as a function of PPG
values was the model without a constant. The estimated
coefficients (0.922 for the right side and 0.939 for the left
side) were significantly different from 0 (p < 0.001) and
close to 1. The coefficient of determination (R2) for the
right and left models were 0.984 and 0.983, respectively.
PPG measurements yielded mean pressure values
7 mmHg higher than LD. However, the Bland and Altman
analysis showed that the difference between the two
methods did not depend on toe pressure values (Fig. 3).
Discussion
This study demonstrated that the fully automatic portable
PPG device that we developed yielded reliable TBP
measurements in patients, regardless of their co-morbid-
ities, and showed good agreement with the reference LD
system over a wide range of values.
PPG measurement yielded, on average, slightly higher
TBP values than LD, although previous studies have repor-
ted the opposite.17 LD is regarded as highly sensitive and
may be able to detect flow in patients with very low TBP in
Table 1 Subjects characteristics.
Total
n Z 198
DMMD
n Z 50
IMD
n Z 50
VMD
n Z 98
Men/women ratio 114/84 60/38 23/27 30/20
Age (years) [mean  SD] 63.78  14.90 65.15  13.59 57.40  14.96 67.55  15.63
PAD [n (%)] 51 (25.6%) 7 (14%) 7 (14%) 37 (37.8%)
Diabetes [n (%)] 109 (55%) 50 (100%) 11 (22%) 48 (49%)
Insulin treated [n (% of diabetics)] 64 (58.7%) 29 (58%) 7 (63.6%) 14 (21.1%)
Hypertension [n (%)] 82 (41.4%) 27 (54%) 9 (18%) 46 (46.9%)
Distal ulcer [n (%)] 23 (11.6%) 1 (2%) 15 (30%) 7 (7.1%)
Smokers [n (%)] 58 (29.3%) 17 (34%) 8 (16%) 46 (46.9%)
DMMD: Diabetes and Metabolic Medicine Department, IMD: Internal Medicine Department, VMD: Vascular Medicine Department, PAD:
Peripheral Arterial Disease.
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no case in our series where LD could detect the return of
blood perfusion while PPG could not. In addition, all
patients with values below the 30 mmHg-threshold defining
ischaemia were detected by both devices. Moreover, the
Bland and Altman analysis showed that the difference
between the two devices was not greater for low than for
normal or high TBP values. Finally, in the PAD subgroup, the
CCC remained satisfactory: 0.869 (0.783e0.922) and 0.911
(0.844e0.950) on the right and left sides, respectively.
Therefore, this small difference may simply reflect the
microcirculation level reached by each technique, with LD
recording flow in smaller vessels in which blood pressure is
lower. From a clinical point of view, this difference seems
irrelevant and PPG appears to be discriminating enough to
detect high-risk subjects.
On the other hand, previous studies18 reported large
variations between PPG and LD, whereas our results
showed a much closer agreement between these two
techniques. This is probably because of the improved
sensitivity and reliability of both state-of-the-art sensors
we used in our study.
PPG signals may be influenced by many physiological
inputs, including respiration, thermoregulation and
sympathetic nervous system activity,19 which may affectTable 2 LD and PPG measurements of toe pressure and toe-br
ficient (CCC) and 95% confidence interval (95%CI) in the whole po
Right lower limb CC
Toe blood pressure
Total (n Z 198) 0.913 (0.885e0.93
DMMD (n Z 50) 0.913 (0.851e0.95
IMD (n Z 50) 0.948 (0.907e0.97
VMD (n Z 98) 0.8969 (0.848e0.93
PAD (n Z 51) 0.869 (0.783e0.92
Diabetes (n Z 109) 0.9059 (0.864e0.93
Hypertension (n Z 82) 0.912 (0.865e0.94
Smokers (n Z 58) 0.920 (0.864e0.95
Toe-brachial systolic pressure index
Total (n Z 198) 0.889 (0.853e0.91
DMMD: Diabetes and Metabolic Medicine Department, IMD: Internal M
Peripheral Arterial Disease.the pulsatile plethysmography curve recorded in the
alternating current (AC) mode, but not the DC curve that
was used by our system to detect the steady upslope
resulting from blood flow return in the toe pulp.
PAD, even if asymptomatic, is a prognostic marker for
total mortality and cardiovascular events.2,18 Therefore, its
early detection could allow improving risk factor control
and reducing the rate of cardiovascular events, thus
ensuring a healthier outcome. In high-risk patients, espe-
cially in diabetics, close follow-up is mandatory. Therefore,
improving the screening, diagnosis and follow-up of PAD
represents a challenge requiring accurate, reliable, simple,
accessible and non-invasive tools. Doppler-measured ABI,
although validated and recommended,6 has significant
limitations and drawbacks, including the required training
and costs.20 Some authors have tested automatic proce-
dures using toe-applied oscillometry,21 oximetry12,22 or PPG
for measuring ankle blood pressure.23 However, none of
these techniques has so far been proven suitable for large-
scale use. In addition, the validity of ABI measurement is
compromised in patients with medial calcinosis, in whom
TBP measurement is more appropriate,8 especially when
ABI is 1.3.10
TBI assessment requires specific, delicate, more or less
cumbersome and costly equipment, which has so farachial systolic pressure index: concordance correlation coef-
pulation sample and in comorbidity subgroups.
C (95%CI) Left lower limb CCC (95%CI)
4) 0.915 (0.888e0.937)
0) 0.9165 (0.854e0.953)
1) 0.919 (0.854e0.956)
1) 0.9091 (0.864e0.940)
2) 0.911 (0.844e0.950)
6) 0.9061 (0.862e0.936)
3) 0.913 (0.865e0.945)
3) 0.918 (0.861e0.953)
6) 0.891 (0.856e0.918)
edicine Department, VMD: Vascular Medicine Department, PAD:
Figure 2 Plot of laser Doppler (LD) toe pressure measurement versus photoplethysmography (PPG) toe pressure measurements
(A) for the right lower limb and (B) for the left lower limb. The full line is the 45 line through the origin which represents the
perfect situation of concordance. The best linear regression model explaining LD measurement values as a function of PPG values
was the model without constant. The equation of the regression line (dotted line) was LDZ 0.922 PPG for the right lower limb and
LD Z 0.939 PPG for the left lower limb.
Figure 3 BlandeAltman plot showing the difference
between photoplethysmography (PPG) and laser Doppler (LD)
toe blood pressure measurement at the right (A) and the left
(B) lower limb in dependency of the mean value of PPG and LD
in each measurement.
Automatic Plethysmographic Toe Pressure Assessment 519precluded its use in out-clinics, outside vascular laborato-
ries. Several devices are available, most of them using
either PPG or LD sensors. During the past few years, some
authors have developed automated monitors for TBP
assessment.24 Among them, the PresTo, first validated in
2002, has been more recently tested in 16 diabetic patients
with ischaemic leg by comparing the automatic software
detection of blood perfusion return to the visual assess-
ment of LD signals.25 In the present study, we compared
values provided by automatic software detection of blood
perfusion return on PPG and on LD signal, and obtained
quite satisfactory results.
In addition, the small PPG device we used is portable,
battery powered, with fully automated reading of blood
pressure, and also of pulp blood draining and occlusion cuff
inflation and deflation, which are either not implemented
or manual on the other systems.
We tested the accuracy of our device over a large range
of pressure values, in patients with or without PAD and co-
morbidities or cardiovascular risk factors. In all groups and
subgroups, the reliability suited the clinical needs, and the
reproducibility was satisfactory.
Although this device requires little formal training, its
reliability implies the adherence to strict methodological
recommendations such as warm room temperature and
supine rest. The cuff width also influences the toe pressure
value and needs to be taken into account in patients with
a very large first toe, or when measurements have to be
performed on another toe because of first toe amputation
or ulceration.26 In addition, the PPG sensor must be
precisely placed with full and stable contact with the skin.
The use of two-sided adhesive tape is useful.
In conclusion, fully automated PPG measurement of TBP
with a small portable device is reliable and accurate. This
technique seems perfectly suitable for large-scale
screening, evaluation, and follow-up of PAD in at-risk
patients, particularly diabetics.
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